FloSpine achieved FDA 510(k) clearance to market the KeyLift Expandable Interlaminar Stabilization System. The device addresses spinal stenosis, introducing a less invasive alternative.
The KeyLift Expandable Interlaminar Stabilization System allows for patient-specific surgical intervention, offering:
Support – KeyLift provides support at the strongest part of the spinal column, the lamina. This distinguishes it from existing devices that only support the spinous process, which is troublesome in patients with osteoporosis.
Lift – With the capacity to expand up to 4mm in height, KeyLift effectively distracts and relieves nerves, alleviating pain caused by spinal stenosis.
Stabilization – Positioned closer to the spine’s instantaneous axis of rotation, KeyLift promotes disc health by balancing the intervertebral discs.
“This is the culmination of years of research and development to deliver a medical device that helps improve the lives of patients suffering from spinal stenosis. Our recent move to larger premises in the Research Park at FAU will allow us to train our surgical and distribution partners to become increasingly competitive in the spinal implant device market,” said Peter Harris, founder and CEO of FloSpine. “This marks two significant achievements for our company as we grow to support our spine devices for both interventional pain physicians and spine surgeons. We are confident that KeyLift will become the standard in treating this condition, offering an overall improved quality of life for patients.”
FloSpine achieved FDA 510(k) clearance to market the KeyLift Expandable Interlaminar Stabilization System. The device addresses spinal stenosis, introducing a less invasive alternative.
The KeyLift Expandable Interlaminar Stabilization System allows for patient-specific surgical intervention, offering: Support – KeyLift provides support at...
FloSpine achieved FDA 510(k) clearance to market the KeyLift Expandable Interlaminar Stabilization System. The device addresses spinal stenosis, introducing a less invasive alternative.
The KeyLift Expandable Interlaminar Stabilization System allows for patient-specific surgical intervention, offering:
Support – KeyLift provides support at the strongest part of the spinal column, the lamina. This distinguishes it from existing devices that only support the spinous process, which is troublesome in patients with osteoporosis.
Lift – With the capacity to expand up to 4mm in height, KeyLift effectively distracts and relieves nerves, alleviating pain caused by spinal stenosis.
Stabilization – Positioned closer to the spine’s instantaneous axis of rotation, KeyLift promotes disc health by balancing the intervertebral discs.
“This is the culmination of years of research and development to deliver a medical device that helps improve the lives of patients suffering from spinal stenosis. Our recent move to larger premises in the Research Park at FAU will allow us to train our surgical and distribution partners to become increasingly competitive in the spinal implant device market,” said Peter Harris, founder and CEO of FloSpine. “This marks two significant achievements for our company as we grow to support our spine devices for both interventional pain physicians and spine surgeons. We are confident that KeyLift will become the standard in treating this condition, offering an overall improved quality of life for patients.”
Copy to clipboard 
